• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); No Known Impact Or Consequence To Patient (2692)
Event Date 05/09/2016
Event Type  Injury  
Event Description
The physician used a venaseal closure system during procedure of the great saphenous vein and the small saphenous vein.Approximately 85cm between both vessels were treated.At the conclusion of the procedure, no issues were identified.It was reported that 4 days post procedure the patient had a follow up ultrasound where it was noted that the common femoral vein was partially occluded.Further information supplied found that prior to initial delivery of adhesive the catheter tip was located 5cm from the junction.Additionally, compression was not held for the entire 3 minutes at the junction.The physician is monitoring the patient and has prescribed blood thinners.
 
Manufacturer Narrative
Two videos were provided for review - video 1 appears to be from a pre-treatment period.The thrombus extension is not apparent in this video.Video 2 is a post-treatment period in which the thrombus extension is seen extending into the common femoral vein.By a crude measurement the thrombus occludes the cfv by 41%, which warrants treatment by anticoagulation.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
COVIDIEN
951 aviation parkway
morrisville NC 27560
Manufacturer (Section G)
COVIDIEN
951 aviation parkway
morrisville NC 27560
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key5694345
MDR Text Key46376886
Report Number3011410703-2016-00013
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 09/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Device Lot Number40495
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight59
-
-